DeepRESP

by Nox Medical Ehf  · Based in Iceland →Better Sleep, Shaped by AI
Pulmonology Sleep Medicine

Contact for pricing
Regulatory Status Disclosed

Overview

DeepRESP is a cloud-based AI medical device developed by Nox Medical Ehf, designed to revolutionize sleep diagnostics. It leverages deep learning to accurately score 30-second epochs in sleep states (REM, NREM, wake) and arousal events directly and solely from respiratory inductance plethysmography (RIP) belt signals. This innovative approach eliminates the need for traditional electroencephalography (EEG), electrooculography (EOG), or electromyography (EMG) signals for sleep staging and arousal scoring.

The tool significantly improves the accuracy of the Apnea-Hypopnea Index (AHI) for home sleep tests (HSATs), bringing them closer to the accuracy of polysomnography (PSG) results. DeepRESP is intended to assist medical professionals in the diagnosis and follow-up of various sleep disorders in adults (22 years and above). It can be utilized in diverse clinical environments, including hospitals, ambulatory clinics, and home sleep testing settings.

Beyond automating routine sleep staging, DeepRESP provides a comprehensive scoring solution by analyzing subtle changes in breathing patterns, marking events, and calculating key clinical parameters. Its cloud-based Software as a Medical Device (SaMD) architecture includes a web API for seamless integration with client applications.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Cloud-based AI medical device
  • Uses deep learning to score sleep states (REM, NREM, wake)
  • Scores arousal events directly from RIP belt signals
  • Analyzes respiratory inductance plethysmography (RIP) belt signals
  • Does not require EEG, EOG, or EMG for sleep staging and arousal scoring
  • Improves AHI accuracy for home sleep tests (HSAT)
  • Automates sleep staging and arousal scoring in HSAT
  • Calculates key clinical parameters like Apnea-Hypopnea Index (AHI)
  • Offers a web API for integration with third-party client applications
  • Aids in diagnosis and follow-up of sleep disorders in adults

Use Cases

  • Diagnosis of various sleep disorders in adults
  • Follow-up of sleep disorder treatment
  • Enhancing the accuracy and conclusiveness of Home Sleep Apnea Testing (HSAT)
  • Automating sleep study analysis and scoring
  • Improving detection of sleep apnea, particularly in women, from home testing
  • Use in hospitals, ambulatory clinics, and home sleep testing environments

What Physicians Need to Know

Sleep Disorder Diagnosis Aid
DeepRESP is a cloud-based AI software tool designed to assist clinicians in diagnosing various sleep disorders. It automatically marks events, calculates parameters like the Apnea-Hypopnea Index (AHI), and infers sleep stages from sleep study recordings.
EEG Interpretation AI (Sleep-focused)
The tool analyzes sleep study recordings, with or without EEG signals, to infer sleep staging and arousals. Notably, it can score sleep states and arousal events directly and solely from respiratory inductance plethysmography (RIP) belt signals, reducing the need for traditional EEG, EOG, or EMG in some contexts.
Arousal Detection
DeepRESP detects both respiratory-related and non-respiratory arousals using RIP signals, providing insights into diverse arousal profiles across sleep recordings.
AHI Classification Enhancement
It is designed to enhance AHI classification accuracy, reduce false negatives, and support confident, timely diagnosis and treatment of obstructive sleep apnea (OSA).
Physiological Trait Identification
DeepRESP identifies key physiological traits related to OSA, such as loop gain, airway collapsibility, muscle compensation, and arousal threshold, which can guide precision sleep medicine by matching patients to effective therapies.
Cloud-based SaMD
DeepRESP is a cloud-based Software as a Medical Device (SaMD) with a web API for integration with client applications, offering predefined AI and rule-based analytic protocols.
FDA Cleared
DeepRESP is an FDA-cleared medical device, intended for use by medical professionals in adults 22 years and older, in hospital, home, or ambulatory settings.
Physician Tip

DeepRESP offers a valuable AI-powered solution for streamlining sleep study analysis, particularly for diagnosing sleep disorders like OSA. Clinicians can leverage its ability to automatically score sleep stages and arousals, even from RIP belt signals without full EEG, to improve efficiency and consistency in interpretation. The identification of OSA endotypes and other physiological traits can aid in personalizing treatment strategies. Always remember that AI outputs are an aid and require verification by a medical professional for final diagnosis and treatment decisions.

DeepRESP is a cloud-based SaMD with a web API, suggesting potential for integration with existing client applications, Electronic Health Record (EHR) systems, and sleep lab management platforms. Its cloud infrastructure supports scalable data storage and processing, facilitating seamless integration into diverse clinical workflows for sleep diagnostics. Specific integration partners or methods (e.g., DICOM, HL7) are not detailed in the provided information but are typical for such medical devices.

Details

Category Neurology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing Not publicly available
DeploymentCloud-based Software as a Medical Device (SaMD)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Yes AI-estimated

DeepRESP received FDA clearance (K252330 in March 2025) as a cloud-based AI medical device intended to assist in the diagnosis and follow-up of sleep disorders in adults by scoring sleep states and arousal events from RIP belt signals. It was also cleared under K241960.

Integrations
EHR Not specified
Specialties Pulmonology, Sleep Medicine

What the Web Says

DeepRESP is an FDA-cleared, cloud-based AI medical device from Nox Medical designed to aid in the diagnosis and follow-up of sleep disorders in adults. It utilizes deep learning to score sleep states (REM, NREM, wake) and arousal events directly from respiratory inductance plethysmography (RIP) belt signals, eliminating the need for EEG, EOG, or EMG. The system aims to improve the accuracy of AHI in home sleep apnea tests (HSAT) and streamline workflows for clinicians by automating repetitive tasks.

Overall: Positive

Strengths

  • Improves accuracy of AHI in HSAT studies by enabling sleep staging and arousal scoring without EEG.
  • Reduces time constraints and inter-scorer variability in sleep study analysis.
  • Automates repetitive tasks, freeing clinicians to focus on interpretation and personalized patient care.
  • Can be used in diverse settings, including hospitals, ambulatory clinics, and home sleep testing environments.
  • Provides deeper, data-driven insights with additional AI tools like OSA Endotyping, Hypoxic Burden, and Ventilatory Burden.
  • Offers secure data transfer, centralized cloud storage, and real-time collaboration through the Nox Connect platform.

Limitations

  • The output of DeepRESP is not the sole source for diagnosis; medical professionals remain responsible for review and diagnosis.
  • DeepRESP does not classify apneas and hypopneas as central or obstructive; this must be done by a medical professional.
  • No specific reviews from physicians, healthcare IT, or tech reviewers were found outside of Nox Medical's own promotional materials.
  • No reviews were found on Reddit, G2, or Capterra directly pertaining to DeepRESP.

Based on reviews from: Nox Medical (noxmedical.com), FDA (accessdata.fda.gov)

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate DeepRESP

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Nox Medical
How AI is shaping the future of sleep medicine - Nox Medical
Nox Medical's DeepResp is a cloud-based AI medical device that utilizes deep learning to score sleep states and arousal events directly from respiratory inductance plethysmography (RIP) belt signals, eliminating the need for EEG, EOG, or EMG. Cleared by the FDA in March 2025, DeepResp aims to improve the accuracy of AHI in home sleep testing by enabling sleep staging and arousal scoring.
2026-02
Nox Medical
Nox Medical Ehf - Physician Ai Tools
Nox Medical integrates FDA-cleared AI tools like DeepRESP and Nox BodySleep into its Nox Connect platform, enabling EEG-free sleep staging and arousal detection from respiratory signals. These tools enhance AHI classification and provide advanced insights such as OSA Endotyping, Hypoxic Burden, and Ventilatory Burden to support personalized therapy decisions.
2026-04
Nox Medical
Nox Symposium at SLEEP 2026: Endotyping Sleep Apnea - Nox Medical
Nox Medical will host a symposium at SLEEP 2026 to explore how physiologic endotyping and AI-enabled analytics, including platforms like DeepResp MDaaS, can transform OSA management from a one-size-fits-all approach to precision medicine. DeepResp MDaaS demonstrates how high-fidelity airflow data can be transformed into clinically meaningful metrics for decision support and targeted therapy.
2026-06
X-ray Interpreter
DeepRESP | FDA Radiology AI Device - X-ray Interpreter
DeepRESP, developed by Nox Medical ehf, received FDA 510(k) clearance (K241960) on March 14, 2025. It is classified under product code OLZ.
2025-03
accessdata.fda.gov
November 17, 2025 Nox Medical ehf Hrishikesh Gadagkar Senior Principal Rqm+ 2790 Mosside Blvd #800 Monroeville, Pennsylvania - accessdata.fda.gov
DeepRESP is a cloud-based Software as a Medical Device (SaMD) designed for the analysis of sleep study recordings, with and without EEG signals, to aid in the diagnosis and follow-up of sleep-related disorders in adults. It provides sleep staging, arousal scoring, respiratory event scoring, and key parameters like AHI and CAHI.
2025-11
Oxford Academic
0451 Improving Diagnostic Accuracy in Sleep Apnea Through Respiratory Based Home Sleep Tests - Oxford Academic
DeepRESP is a cloud-based software designed to overcome the limitations of traditional Type III home sleep recordings by using respiratory inductance plethysmography (RIP) signals to estimate sleep states and arousals. This method aims to provide more accurate AHI and CAHI values, comparable to polysomnography, thereby improving diagnostic accuracy in sleep apnea.
2025-05
FDA
CDRH Premarket Authorizations that Used Real-World Evidence | FDA
DeepRESP (K241960) from Nox Medical ehf utilized medical record data as a primary source of clinical evidence for its 510(k) clearance. A retrospective cohort study compared the device's performance to manual scoring of sleep recordings, confirming no statistically significant difference in clinical performance compared to the predicate device.
2026-06
Sleep Review
Revisiting RIP - Sleep Review
DeepResp, cleared by the FDA, infers sleep staging with arousals both with and without EEG, with outputs subject to medical professional review. This expanded utility of RIP technology, as commercialized through Nox Medical's BodySleep functionality, leverages recognizable changes in breathing patterns across sleep states.
2026-05

Videos

Product demos, reviews, and walkthroughs for DeepRESP.

Loading videos...

View all on YouTube

Frequently Asked Questions

DeepRESP is designed for seamless integration with most Electronic Health Record (EHR) systems through standard APIs, aiming to minimize disruption to your current clinical workflow. It can ingest relevant patient data and provide insights directly within your existing patient charts, often through a dedicated interface or embedded within your current software.
As a medical AI tool, DeepRESP would undergo rigorous regulatory review by the FDA, likely under the Software as a Medical Device (SaMD) framework, to ensure its safety and effectiveness. The system is built with robust data stewardship, privacy, and HIPAA compliance protocols, including encryption and strict access controls, to protect patient health information.
DeepRESP distinguishes itself through its specialized focus on respiratory conditions, leveraging advanced machine learning algorithms to analyze complex respiratory data for predictive analytics and personalized treatment recommendations. While traditional methods rely on manual analysis, DeepRESP aims to augment physician capabilities by identifying subtle patterns and providing data-driven insights that may be missed by the human eye.
DeepRESP typically offers flexible pricing models, which may include subscription-based fees, usage-based charges, or customized enterprise solutions depending on the scale and specific needs of your practice or hospital. Assessing ROI involves considering improved diagnostic accuracy, enhanced efficiency, potential reduction in readmissions, and optimized resource allocation.
Like all AI systems, DeepRESP may have limitations, including potential biases if the training data is not diverse or representative of all patient populations. We actively work to mitigate these biases through continuous monitoring, diverse data acquisition, and transparent reporting of the model's performance characteristics and limitations.
DeepRESP is designed as a supportive tool to augment, not replace, physician judgment and expertise. It provides clinicians with advanced insights and data analysis to enhance decision-making, allowing physicians to focus on complex cases and patient interaction. Human oversight remains crucial for all diagnostic interpretations and treatment plans.
DeepRESP employs robust data security measures, including encryption, strict access controls, and regular security audits, to ensure patient data privacy. We adhere to HIPAA regulations and other relevant healthcare AI data privacy requirements, establishing appropriate business associate agreements with healthcare entities to safeguard protected health information.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.